Deprince Race & Zollo Inc Medtronic PLC Transaction History

Deprince Race & Zollo Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$78.71 - $87.02 $361,908 - $400,117	-4,598 Reduced 1.45%	313,378 $24.7 Million
Q1 2024 May 15, 2024	SELL	$82.84 - $88.09 $862,778 - $917,457	-10,415 Reduced 3.17%	317,976 $27.7 Million
Q4 2023 Feb 14, 2024	BUY	$69.43 - $83.43 $1.59 Million - $1.9 Million	22,832 Added 7.47%	328,391 $27.1 Million
Q3 2023 Nov 14, 2023	SELL	$78.22 - $90.4 $7.56 Million - $8.73 Million	-96,601 Reduced 24.02%	305,559 $23.9 Million
Q2 2023 Aug 14, 2023	SELL	$79.47 - $91.38 $1.13 Million - $1.3 Million	-14,180 Reduced 3.41%	402,160 $35.4 Million
Q1 2023 May 15, 2023	SELL	$76.72 - $87.58 $466,304 - $532,311	-6,078 Reduced 1.44%	416,340 $33.6 Million
Q4 2022 Feb 14, 2023	BUY	$76.18 - $87.74 $4.39 Million - $5.05 Million	57,608 Added 15.79%	422,418 $32.8 Million
Q3 2022 Nov 14, 2022	BUY	$80.75 - $95.31 $466,654 - $550,796	5,779 Added 1.61%	364,810 $29.5 Million
Q2 2022 Aug 15, 2022	BUY	$87.4 - $113.09 $6.86 Million - $8.88 Million	78,488 Added 27.98%	359,031 $32.2 Million
Q1 2022 May 16, 2022	BUY	$100.58 - $112.38 $28.2 Million - $31.5 Million	280,543 New	280,543 $31.1 Million

2,285

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Deprince Race & Zollo Inc, based on Form 13F filings with the SEC.

Stay updated on Deprince Race & Zollo Inc with notifications on news.